Lunit (328130) Stock Outlook 2026: Can the AI Medical Imaging Leader Reach Profitability?
Lunit (KRX 328130) 2026 stock outlook. A qualitative deep dive into Lunit INSIGHT for AI-assisted cancer detection in chest X-ray and mammography, Lunit SCOPE for pathology biomarkers and companion diagnostics, the Volpara acquisition opening the US breast health market, and global pharma partnerships. We weigh the path to profitability against valuation and FDA regulatory risk for this loss-making growth stock.
Lunit 328130 Korea Stocks